Vision correction that leaves your cornea untouched.
The EVO ICL™ is a Collamer lens placed inside the eye, behind the iris. It removes no corneal tissue, it is reversible, and it treats prescriptions far beyond the comfortable range of laser surgery.
Scroll down to explore
A lens that works with your eye, not against it.
The EVO ICL™ is an implantable Collamer lens positioned in the quiet space behind the iris and in front of your natural lens. Once in place, it is invisible from the outside and unfelt from the inside. It simply focuses light, all day, every day.
Nothing is reshaped. Nothing is removed. Your eye keeps its original architecture.
The cornea stays out of it.
LASIK and PRK correct vision by removing corneal tissue, which is why thin corneas are one of the most common reasons patients are turned away from laser surgery.
The EVO ICL™ takes a different route entirely. Because the lens sits inside the eye, corneal thickness is not a barrier. Patients told “your corneas are too thin for LASIK” are often excellent candidates for the EVO ICL™.
Dr. Feinerman performs LASIK, PRK, the EVO ICL™, and refractive lens exchange, so the recommendation you receive is based on your anatomy, not on the one procedure a practice happens to offer.
Where laser surgery stops, the EVO ICL™ is just getting started.
The EVO ICL™ is FDA approved for adults ages 21 to 60 and treats nearsightedness from -3.00 to -20.00 diopters, with or without astigmatism. Very high prescriptions that would require removing too much corneal tissue with a laser are squarely within its range.
FDA approved: ages 21 to 60. Treatment range: -3.00 to -20.00 diopters of nearsightedness, with or without astigmatism. Source: FeinermanVision.com/icl/
Reversible today. Every option preserved for tomorrow.
The EVO ICL™ is reversible: a qualified surgeon can remove it. That matters most decades from now. Every eye eventually develops presbyopia and, later, dysfunctional lens syndrome, and the lens technology available to you at that point depends on what was done to your eye today.
Patients who choose the EVO ICL™ today remain potential candidates for any future technology that corrects near and far vision. Read the 20-year patient case study.
No flap. Corneal nerves largely undisturbed.
Creating a LASIK flap cuts through corneal nerves that drive tear production, which is why dry eye is one of the most discussed side effects of laser vision correction.
The EVO ICL™ involves no flap, so those corneal nerves are largely undisturbed. For patients who already live with dry eye, or who worry about it, the EVO ICL™ carries a lower dry eye impact than LASIK.
Trusted worldwide. Loved by the patients who have it.
More than 4 million implantable collamer lenses have been sold worldwide, and among patients studied, the implantable collamer lens carries a 99.4% satisfaction rate.
One surgeon. Every step. Since 2001.
Feinerman Vision is a boutique, single-surgeon practice. Gregg Feinerman, MD, FACS personally performs every consultation and every surgery, calls his patients the evening of surgery, and sees them himself the next day. There are no hand-offs to outside providers.
Dr. Feinerman was the first surgeon in California to implant the Visian ICL after its 2005 FDA approval, and among the first in California to offer the EVO ICL™ after its 2022 approval: more than 20 years of experience with the implantable collamer lens.
Find out if EVO ICL™ is the right choice for you.
Candidacy comes down to your anatomy, your prescription, and your goals, and only a full evaluation can answer it. If you have been told you are not a LASIK candidate, or you simply want the option that keeps your future open, the EVO ICL™ may be the better fit.
Schedule your consultation(949) 631-4780 · FeinermanVision.com
320 Superior Ave, Suite 390, Newport Beach, CA 92663